NUH (then part of National Healthcare Group), entered into a consultancy service agreement with Mayapada to provide expertise in the development and design of the first Mayapada Hospital in Indonesia.
NUH worked closely with Mayapada to create solutions tailored to meet local needs.
Mayapada aimed to establish a privately - owned for-profit hospital in Indonesia. NUH was engaged into a consultancy service agreement to design the hospital. Opened in 2008.
NUH continues to provide strategic direction and guidance to Mayapada Hospital as part of an ongoing clinical advisory
board engagement.
NUH Global Consultancy partnered with Mandaya Hospital Group to establish a Stem Cell Service Line.
This project began with a detailed gap analysis to identify necessary improvements in infrastructure, clinical expertise, and regulatory compliance.
Mandaya aimed to develop a recognized Center of Excellence in Stem Cell Therapies, including plans to introduce advanced cell therapies like CAR-T over a five-year timeline.
NUH continues to support Mandaya Hospital with clinical advisory services and ongoing protocol development.
NUH Global Consultancy is collaborating with Mandaya Hospital Group to implement a comprehensive Stem Cell Service Clinical Line.
This multi-year project is focused on establishing advanced clinical procedures, training personnel, and equipping the hospital with the necessary facilities to provide cutting-edge stem cell therapies.
Mandaya aims to develop a Stem Cell Service Line that offers advanced therapies in Indonesia.
NUH Global Consultancy conducted a gap analysis at MRCCC to expand and upgrade the capabilities of the anatomical laboratory. The focus was on enhancing subspecialty expertise in pathology and oncology.
Siloam Hospital Group aimed to elevate MRCC’s laboratory’s capacity to support advanced diagnostic and treatment services, particularly in gastrointestinal (GI), liver, lung, breast, gynecological,
and hematological cancers.
